Significant Medication Errors in LTC Facility
Summary
The facility failed to ensure medications were administered in accordance with physician orders for two residents, resulting in significant medication errors. Resident 1, who had a history of atrial fibrillation, coronary artery disease, cerebrovascular accident, seizure disorder, and a heart valve replacement, was prescribed anticoagulants to prevent blood clots. However, there were multiple instances where Coumadin was not administered as ordered, and PT/INR tests were not conducted as required. These omissions were confirmed by the Director of Nursing as significant medication errors. Resident 4, diagnosed with Pick's disease, opioid dependence, and chronic pain syndrome, experienced missed doses of prescribed pain medications, including Fentanyl patches and Oxycodone tablets. The facility's failure to reorder these medications correctly resulted in the resident experiencing increased agitation and confusion, leading to an emergency hospital visit. Interviews with staff revealed a lack of awareness regarding the missing medications and the proper procedure for reordering controlled substances. The facility's policies on medication errors and adverse reactions were not followed, contributing to the deficiencies. The report highlights the failure to administer medications as per the prescriber's orders and the lack of timely communication with the pharmacy and healthcare providers, which led to significant medication errors for both residents.
Removal Plan
- The DNS or designee will identify all other residents on routine narcotics to complete a full audit of eMAR documented administration and verification of medication availability.
- The DNS or designee will educate nurses and CMAs currently working and all other licensed staff prior to working their next shift. Electronic education will be completed with all nurses and CMAs. Education will include expected use and instructions on use of facility emergency medication kit, correct ordering of medication and clear expectation on time and expectation to complete physician ordered PT/INR blood draw, as well as expectation of time deadlines to notify PCP or coumadin clinic, manually entering telephone orders for next INR and coumadin dose.
- The DNS or designated clinical manager will complete all INR draws and notification, while completing follow up education and verification of understanding with nurses.
- The ED or designee will audit staff education completion of the above areas every shift. The DNS or designee will audit eMAR for omissions of missed narcotic prior to end of shift or until substantial compliance is determined. The DNS or designee will audit eMAR and progress notes for omissions of INR completion and PCP notification or until substantial compliance is determined. The above audits will be submitted to QAPI monthly until substantial compliance is determined.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.